Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-Aspirin phase III trial in non-metastatic solid tumors
2013-004398-28Phase 3Unknown
- Sponsor
- MRC Clinical Trials Unit at UCL
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin in breast cancer, colorectal cancer (CRC), gastro-oesophageal junction cancer (GOJ) and 1 more (3 arms), sponsored by MRC Clinical Trials Unit at UCL. Primary endpoints: Overall survival and Cohort-specific co-primary outcome measures. Status: unknown.
02
Drugs
aspirin
03
Conditions
breast cancercolorectal cancer (CRC)gastro-oesophageal junction cancer (GOJ)prostate cancer (PCa)
Beyond the preview
Go deeper on 2013-004398-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004398-28.